Export

EN
FR
Allopurinol
Essential medicine status
Section:
8. Immunomodulators and antineoplastics 8.2. Antineoplastics and supportive medicines 8.2.5. Supportive medicines
ATC codes: M04AA01
EMLc
Indication
Tumour lysis syndrome ICD11 code: 5C70
INN
Allopurinol
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 500 mg (as sodium) powder for injection (EMLc)
Oral > Solid: 100 mg (EMLc) ; 300 mg (EMLc)
EML status history
First added in 2007 (TRS 950)
Changed in 2025 (TRS 1064)
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Allopurinol
DrugBank
Allopurinol
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of allopurinol powder for injection 500 mg to the EMLc for use in the prophylaxis and treatment of tumour lysis syndrome.